1. Home
  2. TCBS vs MREO Comparison

TCBS vs MREO Comparison

Compare TCBS & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Texas Community Bancshares Inc.

TCBS

Texas Community Bancshares Inc.

N/A

Current Price

$17.40

Market Cap

50.6M

Sector

Finance

ML Signal

N/A

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

SELL

Current Price

$0.28

Market Cap

50.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TCBS
MREO
Founded
1934
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.6M
50.3M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
TCBS
MREO
Price
$17.40
$0.28
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $1.96
AVG Volume (30 Days)
3.4K
★ 631.8K
Earning Date
11-10-2026
11-09-2026
Dividend Yield
★ 1.37%
N/A
EPS Growth
★ 327.27
16.67
EPS
★ 0.86
N/A
Revenue
N/A
★ $500,000.00
Revenue This Year
N/A
$59.51
Revenue Next Year
N/A
$2,326.81
P/E Ratio
$20.35
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.72
$0.20
52 Week High
$20.00
$2.37

Technical Indicators

Market Signals
Indicator
TCBS
MREO
Relative Strength Index (RSI) 56.60 41.18
Support Level $17.23 $0.27
Resistance Level $17.92 $0.35
Average True Range (ATR) 0.08 0.02
MACD 0.04 0.00
Stochastic Oscillator 68.89 24.87

Price Performance

Historical Comparison
TCBS
MREO

About TCBS Texas Community Bancshares Inc.

Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans, commercial real estate loans, and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer, and other.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: